Shares of Medtronic PLC MDT rose 2.21% to $86.11 Thursday, on what proved to be an all-around positive trading session for ...

By its label alone, investors who are already jittery about the new economic paradigm may be tempted to avoid medical device ...

This was the stock's second consecutive day of losses.

Medtronic and Boston Scientific both face patient lawsuits related to spinal cord stimulation (SCS) technologies.

The most recent trading session ended with Medtronic (MDT) standing at $84.25, reflecting a -1.01% shift from the previouse trading day's closing. The stock's performance was behind the S&P 500's ...

The medtech giant launched Medtronic Spark: a 10-year initiative designed to attract 1 million low-income students to careers ...

Medtronic has teamed up with Star Jones to get women talking about heart health. The TV personality is lending her star power ...

In the closing of the recent trading day, Medtronic (MDT) stood at $83.62, denoting a +0.55% change from the preceding trading day.

The company also has an excellent dividend profile, having raised its payouts for 47 consecutive years. In just three more years, it will join the prestigious clique of Dividend Kings. That makes ...

This May, during Women’s Health Month and Mother’s Day, we encourage people to make the pledge to talk to their mother or the ...

Medtronic (NYSE:MDT) announced today that it appointed Kate Cronin as the new chief marketing officer for its Diabetes unit.

MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...